Accelitech

Accelitech Expands into Europe, Partners to Create First CyberKnife® Center in Ireland

CHICAGO, March 1, 2012—Accelitech and partners have just completed a transaction to bring the first and only CyberKnife® Stereotactic Radiosurgery System to the Republic of Ireland. Scheduled to begin treating patients in fall of 2012, the center will open on the campus of the Hermitage Medical Clinic in Dublin.

Read more >

The partnership includes the following parties: Accelitech (lead developer), Neurosurgery Ireland (a prominent Irish neurosurgical group), Regent Surgical Health (a developer of high-end specialized surgical programs), the Hermitage Medical Clinic and several other local providers, all of whom share the vision and interest in bringing this state-of-the-art cancer treatment technology to the people of Ireland.

Historically, Irish patients requiring CyberKnife® radiosurgery treatments—and in many cases their treating neurosurgeons—have been required to travel to other countries to complete treatments.

“This partnership is a big win for the people of Ireland,” says Scott Milligan, Chief Development Officer for Accelitech. “The new CyberKnife® program will combine the very best clinical teams in the country with the latest advanced technology in a conveniently located, patient-focused facility.”

About Accelitech LLC
Accelitech LLC is the leading private developer of stereotactic radiosurgery and other technology-based cancer treatment programs. Headquartered in Chicago, IL, Accelitech is a privately held company with extensive experience and resources in healthcare, law, finance, development and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech has sites and projects under development throughout the United States and Europe. For more information, please visit www.accelitech.biz.

About Regent Surgical Health
Regent Surgical Health develops, manages and invests in surgery centers throughout the U.S. Regent has an unmatched record for delivering sustainable profitability while enabling physician partners to maintain clinical autonomy and financial control. We invest capital side by side with physician partners and firmly believe the by-product of excellent care and efficiency is financial success. To learn more about Regent Surgical Health and other physician/hospital alliance opportunities, visit our web site at www.regentsurgicalhealth.com, or email jsimmons@regentsurgicalhealth.com.

About Neurosurgery Ireland
Neurosurgery Ireland is comprised of forward-thinking neurosurgical consultants who have combined forces to bring the latest state-of-the art technology and comprehensive neurosurgical services to the people of Ireland.

About Hermitage Medical Clinic
The Hermitage Medical Clinic is a 101-bed hospital in Lucan, West Dublin, where specialised medical teams provide medical, surgical and advanced radiotherapy care to patients and are supported by the very latest medical technology. The Hermitage Medical Clinic is committed to providing excellence in patient care and we ensure that patients are looked after by competent and caring staff using state-of-the-art facilities in comfortable surroundings. Clinical specialities include surgery, medicine, endoscopy, oncology and interventional diagnostics. We have an eight-bedded ICU/HDU, daycare facility, two linear accelerators for radiotherapy and the Theatre Suite has seven operating rooms. The most up to date radiology equipment is available including MRI, PET/CT, nuclear medicine, 64 slice CT, mammography, ultrasound, X-ray and fluoroscopy.

Read Less >

Accelitech to Open the First CyberKnife Cancer Center Within the City of Chicago

CHICAGO, February 22, 2012 – Accelitech LLC, a leading developer of stereotactic radiosurgery and cancer treatment programs, is pleased to announce its newest CyberKnife cancer center, which will begin treating patients in Chicago in the summer of 2012. Developed through a partnership between Accelitech, physicians and Swedish Covenant Hospital, the new CyberKnife Cancer Institute of Chicago will provide state-of-the-art CyberKnife treatment to patients from Chicago and beyond. This will be the first CyberKnife center within the city limits and will feature the latest technology of its kind in the region. Read more >

Centrally located and conveniently accessible from both downtown and suburban locations, the new 10,000-square-foot facility, now under construction, will be located at 160 East Illinois, in the heart of Chicago. The center will open and the clinical team will begin evaluating patients for treatment beginning this spring.

“Our vision is to create the very best setting for patient care and provide the most advanced cancer treatment technology available in the market,” says Adam Dickler, MD, the Medical Director for the new CyberKnife center. “More than 20 cancer care physicians have been trained to use the CyberKnife, providing new treatment options for their patients.”

“With this and every project, our goal is to bring new technology to patients who need it most, so we’re very excited to add our Chicago site to a rapidly growing network of Accelitech CyberKnife centers,” says Kerwin Brandt, CEO of Accelitech. “With nine existing locations and many more under development, we believe we are the largest and fastest growing private developer of CyberKnife centers in the country.”

About Accelitech LLC
Accelitech LLC is a leading developer of stereotactic radiosurgery and cancer treatment programs. Headquartered in Chicago, IL, Accelitech is a privately held company with extensive experience and resources in healthcare, law, finance, development, and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech has sites and projects under development throughout the United States. For additional information about Accelitech and its services, please visit accelitech.biz.

About CyberKnife Cancer Institute of Chicago by Swedish Covenant Hospital
CyberKnife is the first and only robotic radiosurgery system delivering customizable, non-surgical treatments for a broad range of tumors anywhere in the body. Only the CyberKnife system allows practitioners to non-invasively deliver high doses of radiation to tumors with extreme accuracy and intense precision, providing personalized and tailored treatments that help clinicians pursue the best clinical outcomes for patients’ individual needs. The CyberKnife Cancer Institute of Chicago will open the summer of 2012 and is located at 160 East Illinois, off of Michigan Avenue in Chicago. For more information about the center's opening, visit accelitech.biz.

Read Less >

Accelitech: Now Delivering Cancer Treatment at Two-thirds the Speed of Light

CHICAGO, February 21, 2012 – Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech’s ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals. Read more >

Proton therapy is a cutting-edge cancer treatment that targets tumors with a beam of protons traveling at two-thirds the speed of light. By delivering doses with pinpoint precision, proton therapy is painless, non-invasive and highly effective in treating tumors while minimizing damage to surrounding healthy tissue.

Due to the high cost and large scope of developing a proton therapy center, there are only a handful of places in the U.S. where patients can receive the treatment. With recent lower cost options entering the market, Accelitech hopes to change that by using its existing model to target several proton therapy locations over the next two years.

“The technology may be new, but our model for success remains the same,” says Kerwin Brandt, President and CEO of Accelitech. “Proton therapy is the next generation of cancer treatment, and this project is an exciting opportunity to apply our proven, full-cycle management process to making this state-of-the-art technology available to patients on a broader scale.”

About Proton Beam Therapy
Proton Beam Therapy is a type of external radiotherapy that targets tumors with beams of protons. It has fewer side effects than standard radiation and is proven to be effective in sensitive areas such as the head, spine and prostate. Because of the precise localization and unique behavior of protons, higher dosages can be delivered with unrivaled accuracy, sparing more of the healthy tissue that surrounds the tumor. Proton Beam Therapy is a non-invasive, pain-free procedure that offers a reduced risk of secondary cancer incidents, making it an attractive option for the treatment of growing children.

About Accelitech LLC
Accelitech LLC is a leading developer of technology-driven cancer treatment programs nationwide. Headquartered in Chicago, IL, Accelitech is a privately held company with extensive experience and resources in healthcare, law, finance, development and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech has sites and projects under development throughout the United States. For additional information about Accelitech and its services, please visit accelitech.biz.
Read Less >

Accelitech Launches Elite Oncology Consulting

CHICAGO, IL OCTOBER 2011 — Accelitech has formally launched Elite Oncology Consulting to provide hospital and physician clients with a broad array of advisory services. Though Accelitech has been providing many of these services to its existing technology partners since it was founded in 2005, this new initiative will establish a practice to focus on fully supporting the needs of existing and future clients. Read more >

Accelitech expands its partnership in Louisiana by adding new Varian True Beam Technology

CHICAGO, IL MAY 2011 — Accelitech is pleased to announce that it has acquired and installed a new Varian True Beam adjacent to its existing CyberKnife within Lafayette General Medical Center. The machine is now operational and treating patients. This new technology, which is the latest and most advanced radiation therapy device from Varian Medical Systems, was added to an existing CyberKnife partnership in Lafayette, LA to expand the technological capacity of the program. This is the first and only True Beam operating in Louisiana. Read more >

Accelitech adds 2nd Varian True Beam to its network through a new physician partnership in Tucson, AZ

CHICAGO, IL APRIL 2011 — Accelitech has completed a physician joint venture and has commenced the construction of a new radiation therapy program in Tucson, AZ which is scheduled to begin treating patients in early 2012. The Accelitech Model partnership will focus on the treatment of neurosurgical and urologic conditions using IMRT, IGRT and stereotactic treatments. Accelitech continues to lead the market in creating partnerships around emerging cancer treatment technology. Read more >

Accelitech’s 2nd New Jersey CyberKnife Site Commences Operations

Accelitech Partner, Saint Peter’s University Hospital in New Brunswick, NJ begins treating CyberKnife patients in February 2010

CHICAGO, FEBRUARY 19, 2010 — Accelitech LLC announces the commencement of patient treatments at its new CyberKnife program located in New Brunswick, NJ, a hospital-based facility operated by Saint Peter’s University Hospital. Read more >The acquisition and deployment of the CyberKnife was made possible through a joint venture partnership created by Accelitech. This is the second joint venture of this kind in New Jersey that Accelitech has implemented.

The Accelitech partnership with St. Peter’s joins its other CyberKnife partners including the Hospital of Saint Raphael’s (Connecticut), Cooper University Hospital (New Jersey), Mercy Hospital (Miami), Lafayette General Medical Center (Louisiana), Penrose – St. Francis (Colorado Springs) and Saint Elizabeth’s Regional Medical Center (Nebraska). The Accelitech network continues to grow giving partner’s greater access to leading business and clinical practices for building stereotactic radiosurgery programs. “With increasing market competition throughout the US, Accelitech brings to its hospital partners the experience that makes the difference between success and failure in a given market”, says Jim TeWinkle, Executive Vice President of Accelitech “Simply having the technology is no longer enough. Physician alignment, clinical experience, marketing and operational efficiency are key”.

The proprietary Accelitech model allows hospitals to secure advanced technology that they might not otherwise be able to provide to their patients and physicians. With a full array of support services, the Accelitech Model helps hospitals and physicians to ensure success.

About Accelitech LLC
Accelitech LLC is a leading developer of stereotactic radiosurgery and cancer programs. Headquartered in Chicago, Accelitech is a privately held company with broad experiences and resources in healthcare law, finance, development, and clinical operations. Accelitech provides the capital, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech has sites and projects under development throughout the United States. For more information contact Scott Milligan at (773) 850-3300.

Read Less >

Accelitech’s 7th CyberKnife Opens in Miami

Mercy Hospital and Accelitech have partnered to bring the CyberKnife Stereotactic Radiosurgery System to Miami

CHICAGO, IL JANUARY 4, 2010 — Accelitech LLC, is pleased to announce that its 7th CyberKnife Stereotactic Radiosurgery System has been placed in partnership with Mercy Hospital in Miami, Florida. Read more >

Accelitech to Launch its 6th CyberKnife Program in Partnership with Saint Peter's University Hospital in New Brunswick, NJ

CHICAGO, IL, AUGUST 28, 2009 — Accelitech LLC, a leading developer of stereotactic radiosurgery programs, is pleased to announce the launch of its 6th new CyberKnife Center with Saint Peter’s University Hospital in New Brunswick, NJ. The new technology will be operated by Saint Peter’s as part of its cancer program, which is accredited by the American College of Surgeons. Read more >The CyberKnife is expected to be operational and available to serve the patients of central New Jersey by early 2010.

“The CyberKnife is an exciting new technology option, sometimes referred to as knifeless surgery, for our physicians to offer to their patients who are battling cancer,” said Al Glover, president and chief executive officer at Saint Peter’s University Hospital, a member of Saint Peter’s Healthcare System. “Enhancing tumor targeting allows for greater precision which translates into the safe delivery of higher doses of radiation therapy and the need for fewer patient treatments.”

“Despite these challenging economic times, it was essential for Saint Peter’s to obtain the latest in radiation therapy technology by bringing the CyberKnife to our market,” said Garrick Stoldt, chief financial officer at Saint Peter’s. “With the addition of the CyberKnife to our accredited cancer program, we’ve created the best cancer treatment program in the region.”

“Many hospitals like Saint Peter’s strive to build and grow leading cancer programs despite the financial challenges facing the healthcare system throughout the United States” said Scott Milligan, the chief development officer of Accelitech. “Our proven model allows hospital’s like Saint Peter’s to deliver new, competitive technology without the large capital outlay. We act in essence as the capital partner and safety net. With that, our business is experiencing a spike in demand as hospitals and health systems around the country wrestle with these very challenging and real issues.”

About Accelitech LLC

Accelitech LLC is a leading developer of stereotactic radiosurgery programs. Headquartered in Chicago, Accelitech offers broad experience and resources in healthcare law, finance, development, and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech currently has seven sites in addition to many projects under development throughout the United States. Read Less >

Accelitech to Sponsor Customer Service Workshop at Accuray User Meeting

CHICAGO, IL, DECEMBER 17, 2008 — On Thursday, February 5, 2009, Accelitech will host a presentation to promote customer service values for Accuray CyberKnife™ users in conjunction with Accuray’s CyberKnife User’s meeting. Read more >

Accelitech Announces Launch of its Elite Management System

CHICAGO, IL, NOVEMBER 19, 2008 — Accelitech has announced the launch of the Elite Management System, a cancer program and SRS-specific management tool for Accelitech sites. The system will help centers optimize the outcomes of SRS applications, by delivering tools to track performance, monitor patients and establish benchmarks. Read more >

Accelitech Financing Remains Strong Despite Credit Market Turmoil

CHICAGO, IL, NOVEMBER 12, 2008 — "Accelitech maintains access to non-recourse capital," states Kerwin Brandt, CEO of Accelitech. The current credit market crisis has broadly impacted our hospital and physician clients' ability to fund capital intense projects. However, their need for acquiring emerging technology in order to remain competitive has not changed. Read more >

Accelitech Presents at 2008 Cancer Center Business Summit

Market for New Technology Continues to be Strong in face of Credit Crisis and Capital Gap

CHICAGO, IL, OCTOBER 23, 2008 — Accelitech LLC, a leading developer of stereotactic radiosurgery and cancer treatment programs, spoke to industry peers in a two-day conference on October 20 and 21 aimed at addressing legal and business issues in the field of cancer care delivery. Read more >

Scott D. Milligan, Chief Development Officer of Accelitech, presented the following key points in his presentation titled New Technology: Economics and Joint Ventures in Radiosurgery:

Demand for SRS continues to be strong, driven by clinical outcomes, patient awareness and hospital business opportunity.
Technology options for SRS are increasing and creating market confusion and opportunity.
The hospital “capital gap” continues to widen with the credit crisis and market meltdown.
New Stark laws have made physician ventures more challenging (but possible), particularly when surgeons are involved.
The Accelitech Joint Venture Model may provide hospitals with attractive off balance sheet, per-use, no minimum lease arrangements.
All indications are that the Stereotactic Radiosurgery market will continue to be attractive for hospitals, patients, physicians and the developers who support them.

About 2008 Cancer Center Business Summit
The 2008 Cancer Center Business Summit, “Community Oncology at the Crossroads” was sponsored in part by Foley & Lardner LLP. The purpose of the event is to confront issues affecting community-based oncology providers as these entities experience declining reimbursements for chemotherapy and imaging services and increasing technology costs and competition in radiation therapy. The event was widely attended, attracting providers, payers, attorneys and developers alike.

About Accelitech LLC
Accelitech LLC is a leading developer of stereotactic radiosurgery programs. Headquartered in Chicago, Accelitech offers broad experience and resources in healthcare law, finance, development, and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech currently has six sites in addition to several other projects under development throughout the United States. For more information contact Scott Milligan at (773) 850-3300. accelitech.biz Read Less >

Accelitech's Fifth CyberKnife Center to Open in Colorado Springs

Penrose Cancer Center will be the first in the region to secure CyberKnife Robotic Stereotactic Radiosurgery

CHICAGO, IL, OCTOBER 22, 2008 — Accelitech LLC, a leading developer of stereotactic radiosurgery programs, is pleased to announce the launch of a new CyberKnife Center with Penrose-St. Francis Health Services in Colorado Springs, Colorado. Read more >The Accuray CyberKnife System was obtained through a joint venture created by Accelitech in partnership with physicians and the hospital. The Penrose Cancer Center expects to begin treating patients on the CyberKnife in the summer of 2009.

The Accuray CyberKnife Robotic Radiosurgery System is used primarily to ablate tumors as well as for other procedures as an alternative to invasive surgery. The Penrose Cancer Center will be the first and only hospital in southern Colorado to utilize the CyberKnife system. With this addition, the center offers one of the most complete arrays of radiation oncology tools in the state.

“With Penrose-St. Francis acquiring the only robotic radiosurgery system with proven sub-millimeter accuracy, we can make untreatable and unreachable tumors a thing of the past,” said Dr. Anuj Peddada, radiation oncologist for the Penrose Cancer Center. “Because of its unrivaled accuracy, we can deliver the entire treatment, non-invasively, in one to five treatments.”

Kerwin Brandt, CEO of Accelitech LLC, said, “We are pleased to be working with one of the premier cancer treatment centers in the region and the state. The highly respected physicians and staff at the Penrose Cancer Center are excellent partners for this venture, and all of us are looking forward to the enhanced patient care they will provide.”

“The completion of the Penrose-St. Francis Health Services joint venture represents Accelitech’s fifth CyberKnife transaction since the company’s inception in 2005,” said Scott Milligan, Chief Development Officer of Accelitech, “With the addition of our Joint Venture with Penrose, Accelitech is positioned as the national leader in completed transactions for new CyberKnife locations.”

About Accelitech LLC
Accelitech LLC is a leading developer of stereotactic radiosurgery programs. Headquartered in Chicago, Accelitech offers broad experience and resources in healthcare law, finance, development, and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve.

About Penrose-St. Francis Health Services
Penrose-St. Francis Health Services is a leading provider of health services in the Southern Colorado Market comprised of 2,600 healthcare professionals serving several locations in the Pikes Peak Region, including Penrose Hospital, St. Francis Medical Center, St. Francis Health Center, Penrose Community Urgent Care, Langstaff-Brown Urgent Care Center (Woodland Park), Health Learning Center, Colorado Sports and Spine Centers, and Profile Employee Assistance Program.

For more information contact Scott Milligan (773) 850-3300. accelitech.biz Read Less >

TECHNOLOGY.
FASTER.
together.

Partnerships to Create and Deliver Cutting-Edge
Cancer Treatment Centers

The Technology to
Succeed. Accelerated.

Management

developing a center

Our Partners

News

Case Studies

TECHNOLOGY. FASTER. together.

Partnerships to Create and Deliver Cutting-Edge Cancer Treatment Centers

The Technology to Succeed. Accelerated.